Viewing Study NCT01427335


Ignite Creation Date: 2025-12-24 @ 10:15 PM
Ignite Modification Date: 2025-12-25 @ 7:50 PM
Study NCT ID: NCT01427335
Status: COMPLETED
Last Update Posted: 2014-07-09
First Post: 2011-08-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Calcium for Prevention of Ovarian Hyperstimulation Syndrome
Sponsor: Cairo University
Organization:

Study Overview

Official Title: Does Intravenous Calcium Infusion Effectively Prevent OHSS : a Randomised Controlled Trial
Status: COMPLETED
Status Verified Date: 2014-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: OHSS
Brief Summary: There are many protocols for prevention of ovarian hyperstimulation syndrome, intravenous calcium is a novel protocol. But still there is lack of evidence of it is real effect in prevention of OHSS \& the mechanism of its action is still questionable . In the study the investigators try to search for the evidence for its effect \& the real mechanism for its action.
Detailed Description: The study population will be divided into 2groups each containing 100 infertile couples candidate for ICSI.

Group (A)active group: administration of 10% Intravenous calcium gluconate 10 ml in 200 mL of physiologic saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup. Intravenous infusion was performed within 30 minutes.

Group (B): placebo group: administration of 200 mL of 0.9% saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup. Intravenous infusion was performed within 30 minutes

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: